Board of Directors

PP 310x206    

Paolo Paoletti, M.D.

Italian (USA Citizenship), 66, Male 
Chairman of the Scientific Committee 
First elected 2015, current term expires 2017
 
Special Competences
Extensive experience in research, development and commercialization in the pharmaceutical industry. Successfully conducted submissions and approvals of new cancer drugs and new indications in the USA and in Europe. Responsible for seven new medicines for cancer patients during his 10 years at GlaxoSmithKline and one new cancer medicine during his time at Eli Lilly.
 
Current Position, including Managerial Positions
CEO of GammaDelta Therapeutics Limited
 
Current Board Positions
Chairman: PsiOxus Therapeutics Limited
Member: FORMA Therapeutics and NuCana BioMed Limited

Back To Board of Directors